Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 15:04:36 - browse：6628

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： STAT Report: Patient voices and perspectives

WSS

Why patients can’t get everything they want on drug pricing

The haunting brain science of long Covid

What Henrietta Lacks's story taught me about my role as a doctor

UHS says company favors patients whose insurance pays more

Doctors have an ethical obligation to be advocates

Device maker Teleflex to acquire urology company for $600M

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

At least 13 dead in Texas as scorching temps continue

UHS says company favors patients whose insurance pays more

Activists slam private health insurers over coverage restrictions

Search called off for baby washed away in Pennsylvania flash flood

What does generative AI mean for health care? We asked experts

The haunting brain science of long Covid

The high cost of giving birth even with insurance

Men with early prostate cancer can safely opt out of treatment

Continuity nursing helped my family in our darkest PICU moments

My chronic pain journey would have been easier knowing 5 things % STAT

hotspot

FDA approves first blood sugar monitor without finger pricks

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Where does female orgasm come from? Scientists think they know

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

'Investigate these claims': UFO transparency at center of House hearing

Sophia Smith scores twice for US in in 3

leisure time

hotspot

hotspot

knowledge